Close

Analyst Ratings for GlaxoSmithKline (GSK)

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $46.00 (+9.2%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/4/2024 Guggenheim Seamus Fernandez Upgrade Buy
(Neutral)
N/A
(N/A)
41.90
(42.14)
0.57% Details
1/23/2024 Morgan Stanley Mark Purcell New Coverage Equalweight
(N/A)
44.00
(N/A)
39.68
(42.14)
6.2% Details
Like GSK Ratings? Also take a look at PFE, BLU, SCYX, GILD

GSK Ratings News